Literature DB >> 33603971

Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead.

Joseph A Ippolito1,2, Haichan Niu1, Nicole Bertoletti2, Zachary J Carter1, Shengyan Jin2, Krasimir A Spasov2, José A Cisneros1, Margarita Valhondo1, Kara J Cutrona1, Karen S Anderson2,3, William L Jorgensen1.   

Abstract

Covalent inhibitors of wild-type HIV-1 reverse transcriptase (CRTIs) are reported. Three compounds derived from catechol diether non-nucleoside inhibitors (NNRTIs) with addition of a fluorosulfate warhead are demonstrated to covalently modify Tyr181 of HIV-RT. X-ray crystal structures for complexes of the CRTIs with the enzyme are provided, which fully demonstrate the covalent attachment, and confirmation is provided by appropriate mass shifts in ESI-TOF mass spectra. The three CRTIs and six noncovalent analogues are found to be potent inhibitors with both IC50 values for in vitro inhibition of WT RT and EC50 values for cytopathic protection of HIV-1-infected human T-cells in the 5-320 nM range.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 33603971      PMCID: PMC7883463          DOI: 10.1021/acsmedchemlett.0c00612

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  28 in total

1.  Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue.

Authors:  Olugbeminiyi O Fadeyi; Lise R Hoth; Chulho Choi; Xidong Feng; Ariamala Gopalsamy; Erik C Hett; Robert E Kyne; Ralph P Robinson; Lyn H Jones
Journal:  ACS Chem Biol       Date:  2017-07-20       Impact factor: 5.100

Review 2.  Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment.

Authors:  Yali Wang; Erik De Clercq; Guangdi Li
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-10-17       Impact factor: 4.481

3.  Two-Drug Regimen for HIV.

Authors:  Feyza Sancar
Journal:  JAMA       Date:  2019-05-21       Impact factor: 56.272

4.  LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands.

Authors:  Leela S Dodda; Israel Cabeza de Vaca; Julian Tirado-Rives; William L Jorgensen
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

5.  From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.

Authors:  Shalley N Kudalkar; Jagadish Beloor; Elias Quijano; Krasimir A Spasov; Won-Gil Lee; José A Cisneros; W Mark Saltzman; Priti Kumar; William L Jorgensen; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

6.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

Review 7.  Single-Tablet Regimens for the Treatment of HIV-1 Infection.

Authors:  Jamielynn C Sebaaly; Denise Kelley
Journal:  Ann Pharmacother       Date:  2016-11-28       Impact factor: 3.154

8.  Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection.

Authors:  Shalley N Kudalkar; Jagadish Beloor; Albert H Chan; Won-Gil Lee; William L Jorgensen; Priti Kumar; Karen S Anderson
Journal:  Mol Pharmacol       Date:  2017-02-06       Impact factor: 4.436

Review 9.  Lysine-Targeting Covalent Inhibitors.

Authors:  Jonathan Pettinger; Keith Jones; Matthew D Cheeseman
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-27       Impact factor: 15.336

10.  Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.

Authors: 
Journal:  Lancet HIV       Date:  2019-08-19       Impact factor: 16.070

View more
  2 in total

1.  Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase.

Authors:  Kathleen M Frey; Nicole Bertoletti; Albert H Chan; Joseph A Ippolito; Mariela Bollini; Krasimir A Spasov; William L Jorgensen; Karen S Anderson
Journal:  Front Mol Biosci       Date:  2022-02-14

Review 2.  Recent advances in the development of covalent inhibitors.

Authors:  Hyunsoo Kim; Yoon Soo Hwang; Mingi Kim; Seung Bum Park
Journal:  RSC Med Chem       Date:  2021-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.